Company intelligence / Profile preview

Relu

Leuven, Belgium

Ownership: Private
Development stage: Other

Overview

Relu’s AI-driven dental software with FDA 510(k) and CE marking automates digital dental design and planning, currently supporting over 40,000 cases monthly for labs and clinics in Europe, North America, and East Asia[1][3][4].

Therapeutic areas: OtherPulmonology
Industry: Digital Health Medical Devices

Partnerships

Dental Innovation AllianceCareCapital

Beyond the preview

Go deeper on Relu.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relu.

Explore the full profile